<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: Formulation for Bioavailability</title><link>http://www.bing.com:80/search?q=Formulation+for+Bioavailability</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>Formulation for Bioavailability</title><link>http://www.bing.com:80/search?q=Formulation+for+Bioavailability</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>The Bioavailability of Drugs—The Current State of Knowledge - MDPI</title><link>https://www.mdpi.com/1420-3049/28/24/8038</link><description>The importance of drug bioavailability research is highlighted for improving therapy effectiveness, personalizing treatment, minimizing side effects, and developing new drugs and formulations [12]. Bioavailability is also important for treating rare diseases, with limited effectiveness [13].</description><pubDate>Sun, 05 Apr 2026 05:56:00 GMT</pubDate></item><item><title>Monoclonal antibody and protein therapeutic formulations for ...</title><link>https://pmc.ncbi.nlm.nih.gov/articles/PMC10793682/</link><description>Subcutaneous formulation considerations In this section, we review six key variables in drug formulation: volume, concentration, viscosity, osmolality and tonicity, pH, and bioavailability. These variables are interrelated: changes in one can affect the others.</description><pubDate>Wed, 25 Mar 2026 21:19:00 GMT</pubDate></item><item><title>Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid ...</title><link>https://www.mdpi.com/1999-4923/17/1/63</link><description>Self-emulsifying drug delivery systems (SEDDS) represent an innovative approach to improving the solubility and bioavailability of poorly water-soluble drugs, addressing significant challenges associated with oral drug delivery. This review highlights the advancements and applications of SEDDS, including their transition from liquid to solid forms, while addressing the formulation strategies ...</description><pubDate>Fri, 03 Apr 2026 03:43:00 GMT</pubDate></item><item><title>Advances in nutraceutical delivery systems: From formulation design for ...</title><link>https://www.sciencedirect.com/science/article/pii/S0924224418300608</link><description>Scope and approach In the present review the recent innovations regarding the formulation and design of bio-based micro and nano-delivery systems to encapsulate nutraceuticals is discussed; it also gives an overview of the challenges associated to their development; and highlights some strategies to enhance nutraceuticals' bioavailability.</description><pubDate>Sat, 04 Apr 2026 22:11:00 GMT</pubDate></item><item><title>Buprenorphine and its formulations: a comprehensive review</title><link>https://pmc.ncbi.nlm.nih.gov/articles/PMC9392838/</link><description>The buccal film formulation of buprenorphine has a higher bioavailability than other formulations, making it the most effective delivery method besides intravenous. 23,24 Both the buccal and transdermal formulations bypass first-pass gastrointestinal and hepatic metabolism, which could make these good analgesic options, especially for patients ...</description><pubDate>Sat, 07 Mar 2026 01:01:00 GMT</pubDate></item><item><title>Drug Bioavailability - an overview | ScienceDirect Topics</title><link>https://www.sciencedirect.com/topics/medicine-and-dentistry/drug-bioavailability</link><description>Bioavailability. Bioavailability (F) describes the fraction of a dose of drug that reaches the systemic circulation. Bioavailability of a single drug may vary significantly depending on the route of administration. By routes other than intravenous, absorption is a primary determinant of F. In enteral administration, an additional factor influences F. Excluding drugs primarily absorbed by the ...</description><pubDate>Fri, 03 Apr 2026 17:33:00 GMT</pubDate></item><item><title>Oral iron supplementation: new formulations, old questions - PMC</title><link>https://pmc.ncbi.nlm.nih.gov/articles/PMC11367235/</link><description>Iron-deficiency anemia and pre-anemic iron deficiency are the most frequent pathologies. The first line of treatment involves oral iron supplementation. The simplest, least expensive, and most commonly prescribed drug is ferrous sulfate, while other ...</description><pubDate>Thu, 02 Apr 2026 06:29:00 GMT</pubDate></item><item><title>A Bioequivalence Study of Two Formulations of Oral Semaglutide in ...</title><link>https://pmc.ncbi.nlm.nih.gov/articles/PMC11794934/</link><description>A second-generation (2G) oral semaglutide formulation has been developed with improved oral bioavailability and equivalent exposure at lower doses of the active pharmaceutical ingredient, semaglutide. This was evaluated against the initial, first-generation (1G) formulation in a previous comparative bioavailability study (NCT04097600) [27].</description><pubDate>Sun, 29 Mar 2026 04:10:00 GMT</pubDate></item><item><title>Lipid-based oral formulation in capsules to improve the delivery of ...</title><link>https://www.frontiersin.org/journals/drug-delivery/articles/10.3389/fddev.2023.1232012/full</link><description>The formulation of the rosuvastatin SLNs improved oral bioavailability by 2.2 times when compared to a control suspension because it avoided the effects of first pass metabolism by exploiting the lymphatic transport channel (Dudhipala and Ay, 2020).</description><pubDate>Sun, 29 Mar 2026 01:18:00 GMT</pubDate></item><item><title>Subcutaneous Administration of Monoclonal Antibodies: Pharmacology ...</title><link>https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3150</link><description>Additionally, information collected on the effect of formulation pH and viscosity, rate of delivery, needle gauge used, and the effect of the site of injection on bioavailability and possibility of increased immunogenicity should be considered when designing s.c. formulations and device presentations such as vial and syringe, pre-filled ...</description><pubDate>Sat, 04 Apr 2026 00:28:00 GMT</pubDate></item></channel></rss>